Therapeutic Area | MeSH |
---|---|
urogenital diseases | D000091642 |
signs and symptoms pathological conditions | D013568 |
Tradename | Company | Number | Date | Products |
---|---|---|---|---|
CRINONE | AbbVie | N-020701 RX | 1997-07-31 | 2 products, RLD, RS |
ENDOMETRIN | Ferring Pharmaceuticals | N-022057 RX | 2007-06-21 | 1 products, RLD, RS |
PROMETRIUM | Virtus Pharmaceuticals | N-019781 RX | 1998-05-14 | 2 products, RLD |
Tradename | Company | Number | Date | Products |
---|---|---|---|---|
BIJUVA | Mayne Group | N-210132 RX | 2018-10-28 | 2 products, RLD, RS |
Brand Name | Status | Last Update |
---|---|---|
advanced formula progesto-life | unapproved drug other | 2022-03-31 |
bijuva | New Drug Application | 2025-01-28 |
crinone | New Drug Application | 2024-05-21 |
endometrin | New Drug Application | 2022-08-16 |
estradiol and progesterone | ANDA | 2024-06-07 |
fluocinolone acetonide 0.01% / minoxidil 7% / progesterone 0.1% | unapproved drug other | 2019-05-08 |
minoxidil 5% / progesterone 0.1% / tretinoin 0.025% | unapproved drug other | 2019-05-06 |
minoxidil 7% / progesterone 0.1% | unapproved drug other | 2019-04-24 |
minoxidil 7% / progesterone 0.1% / tretinoin 0.025% | unapproved drug other | 2019-05-06 |
p25 progesterone cream | unapproved drug other | 2021-06-21 |
Expiration | Code | ||
---|---|---|---|
PROGESTERONE, MILPROSA, FERRING PHARMS INC | |||
2023-04-29 | NP |
Patent | Expires | Flag | FDA Information |
---|---|---|---|
Estradiol / Progesterone, Bijuva, Mayne Pharma | |||
8633178 | 2032-11-21 | DP | |
8846648 | 2032-11-21 | U-2439 | |
8846649 | 2032-11-21 | DP | U-2439 |
8933059 | 2032-11-21 | DP | U-2439 |
8987237 | 2032-11-21 | DP | |
8993548 | 2032-11-21 | DP | |
8993549 | 2032-11-21 | DP | |
9006222 | 2032-11-21 | DP | U-2439 |
9114145 | 2032-11-21 | U-2439 | |
9114146 | 2032-11-21 | DP | U-2439 |
9301920 | 2032-11-21 | DP | U-2439 |
10052386 | 2032-11-21 | DP | |
10206932 | 2032-11-21 | U-2439 | |
10639375 | 2032-11-21 | DP | |
10675288 | 2032-11-21 | U-2439 | |
10806740 | 2032-11-21 | DP | U-2439 |
11033626 | 2032-11-21 | DP | U-2439 |
11103513 | 2032-11-21 | U-2439 | |
11103516 | 2032-11-21 | DP | |
11110099 | 2032-11-21 | DP | |
11166963 | 2032-11-21 | DP | |
11529360 | 2032-11-21 | DP | |
Progesterone, Milprosa, Ferring Pharms Inc | |||
8580293 | 2030-01-21 | U-2810 | |
10537584 | 2029-02-03 | DP | |
10548904 | 2029-02-03 | U-2810 |
Code | Description |
---|---|
J1050 | Injection, medroxyprogesterone acetate, 1 mg |
J1726 | Injection, hydroxyprogesterone caproate, (makena), 10 mg |
J1729 | Injection, hydroxyprogesterone caproate, not otherwise specified, 10 mg |
J2675 | Injection, progesterone, per 50 mg |
S3620 | Newborn metabolic screening panel, includes test kit, postage and the laboratory tests specified by the state for inclusion in this panel (e.g., galactose; hemoglobin, electrophoresis; hydroxyprogesterone, 17-d; phenylalanine (pku); and thyroxine, total) |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Healthy volunteers/patients | — | — | — | — | — | 1 | — | — | 1 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Hemostasis | D006487 | — | — | — | 2 | — | — | — | 2 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Pharmacokinetics | D010599 | — | — | 1 | — | — | — | — | 1 |
Drug common name | Progesterone |
INN | progesterone |
Description | Progesterone is a C21-steroid hormone in which a pregnane skeleton carries oxo substituents at positions 3 and 20 and is unsaturated at C(4)-C(5). As a hormone, it is involved in the female menstrual cycle, pregnancy and embryogenesis of humans and other species. It has a role as a contraceptive drug, a progestin, a progesterone receptor agonist, a human metabolite and a mouse metabolite. It is a 20-oxo steroid, a 3-oxo-Delta(4) steroid and a C21-steroid hormone. It derives from a hydride of a pregnane. |
Classification | Small molecule |
Drug class | progestins; steroids (androgens, anabolics); antiandrogens |
Image (chem structure or protein) | ![]() |
Structure (InChI/SMILES or Protein Sequence) | CC(=O)[C@H]1CC[C@H]2[C@@H]3CCC4=CC(=O)CC[C@]4(C)[C@H]3CC[C@]12C |
PDB | — |
CAS-ID | 57-83-0 |
RxCUI | — |
ChEMBL ID | CHEMBL103 |
ChEBI ID | 17026 |
PubChem CID | 5994 |
DrugBank | DB00396 |
UNII ID | 4G7DS2Q64Y (ChemIDplus, GSRS) |